Digital Repository

Risk Factors for Loss to Follow-Up in Human Immunodeficiency Virus Care in the Greater Accra Regional Hospital in Ghana: A Retrospective Cohort Study

Show simple item record

dc.contributor.author Sifa, Jerry S
dc.contributor.author Manortey, Stephen
dc.contributor.author Talboys, Sharon
dc.contributor.author Ansa, Gloria A.
dc.contributor.author Houphouet, Ekua E.
dc.date.accessioned 2023-02-13T09:05:20Z
dc.date.available 2023-02-13T09:05:20Z
dc.date.issued 2019-06-11
dc.identifier.citation Jerry S Sifa, Stephen Manortey, Sharon Talboys, Gloria A Ansa, Ekua E Houphouet, Risk factors for loss to follow-up in human immunodeficiency virus care in the Greater Accra Regional Hospital in Ghana: a retrospective cohort study, International Health, Volume 11, Issue 6, November 2019, Pages 605–612, https://doi.org/10.1093/inthealth/ihz043 en_US
dc.identifier.issn 1876-3405
dc.identifier.uri https://doi.org/10.1093/inthealth/ihz043
dc.identifier.uri http://41.204.63.118:8080/xmlui/handle/123456789/24
dc.description Research Article en_US
dc.description.abstract Background: Loss of human immunodeficiency virus (HIV)-positive patients to follow-up increases HIV-related morbidity and mortality. This study identified the factors associated with loss to follow-up (LTFU) in an urban health facility in Ghana. Methods: A 12-y retrospective study was conducted using routinely collected data from the National Acquired Immune Deficiency Syndrome (AIDS) Control Programme (NACP) on persons living with HIV/AIDS (PLWHA) who initiated antiretroviral therapy (ART) from 2006 to 2017 at the Greater Accra Regional Hospital. Convenience sampling was used to select the study area. All gathered data were exported to Stata 14 statistical software for analysis. Results: A total of 4330 PLWHA initiated ART between January 2006 and December 2017. Of these, 1166 (26.9%) were lost to follow-up over the 12-y period. The factors associated with LTFU included being a Muslim (adjusted hazard ratio [aHR] 1.31 [95% confidence interval {CI} 1.05 to 1.65]), having CD4 <250 cells/ml (aHR 1.45 [95% CI 1.21 to 1.76]) and completing adherence counselling (aHR 1.58 [95% CI 1.31 to 1.92]). Having other sources of health care funding and disclosure of one’s disease status were found to be protective (aHR 0.74 [95% CI 0.58 to 0.94] and 0.80 [95% CI 0.65 to 0.98], respectively). Conclusions: Some of the determinants of LTFU in the hospital are comparable to those found in other parts of Africa and could be addressed using existing interventions. en_US
dc.language.iso en en_US
dc.publisher Oxford University Press (International Health) en_US
dc.relation.ispartofseries Volume 11;6
dc.subject Africa en_US
dc.subject Antiretroviral Therapy en_US
dc.subject Ghana en_US
dc.subject HIV/AIDS en_US
dc.subject Loss to Follow-up en_US
dc.title Risk Factors for Loss to Follow-Up in Human Immunodeficiency Virus Care in the Greater Accra Regional Hospital in Ghana: A Retrospective Cohort Study en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Ensign Digital Repository


Advanced Search

Browse

My Account